The clinical application of a urine albumin: Creatinine ratio point-of-care device

Clinica Chimica Acta

Volumn 307, Issue 1-2, 2001, Pages 15-21

  Croal, Bernard L ^a,b   Mutch, W J ^b   Clark, B M ^b   Dickie, A ^b   Church, J ^b   Noble, D ^b   Ross, I S ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b NHS GRAMPIAN   (United Kingdom)

Author keywords

Diabetes mellitus; Intensive care; Microalbuminuria

Indexed keywords

ALBUMIN; CREATININE;

ALBUMIN BLOOD LEVEL; ARTICLE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; LENGTH OF STAY; MICROALBUMINURIA; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RISK MANAGEMENT; URINALYSIS;

ALBUMINURIA; CREATININE; DIABETES MELLITUS; HUMANS; INTENSIVE CARE UNITS; POINT-OF-CARE SYSTEMS; SENSITIVITY AND SPECIFICITY;

EID: 0035026910     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(01)00450-8     Document Type: Article

References (14)

1. Rowe D.J.F., Dawney A., Watts G.F. Microalbuminuria in diabetes mellitus: review and recommendations for the measurement of albumin in urine. Ann. Clin. Biochem. 27:1990;297-312.
2. Marshall S.M. Screening for microalbuminuria: which method. Diabetes Med. 8:1991;706.
3. Morgensen C.E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetics. N. Engl. J. Med. 310:1984;66.
4. Andrzej S., Krowlewski M.D., Lori M.B., Laffel M.D., Krowlewski M., Quinn M., Warram J.H. Glycosylated haemoglobin and the risk of microalbuminuria in patients with insulin dependent diabetes mellitus. N. Engl. J. Med. 329:1993;977-986.
5. The effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int. 47:1995;1705-1720.
6. Mogensen C.E., Keane W.F., Bennet P.H., Jerums G., Parving H.H., Passa P.et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet. 346:1995;1080-1084.
7. Gosling P. Microalbuminuria: a marker of systemic disease. Br. J. Hosp. Med. 54:1995;285-290.
8. Gosling P. Microalbuminuria: a sensitive indicator of non-renal disease. Ann. Clin. Biochem. 32:1995;439-441.
9. Jensen J.S., Borch-Johnsen K., Jensen G., Feldt-Rasmussen B. Microalbuminuria reflects a generalised trans-vascular albumin leakiness in clinically healthy subjects. Clin. Sci. 88:1995;629-633.
10. Pallister I., Gosling P., Alpar E.K., Bradley S. Prediction of post-traumatic adult respiratory distress syndrome by albumin excretion rate eight hours after admission. J. Trauma. 42:1997;1056-1061.
11. Damsgaard E.M., Froland A., Jorgensen O.D., Mogensen C.E. Microalbuminuria as predictor of increased mortality in elderly people. BMJ. 300:1990;297-300.
12. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit. Care Med. 13:1985;818-829.
13. Parsons M., Newman D.J., Pugia M., Newall R.G., Price C.P. Performance of a reagent strip device for quantification of the urine albumin:creatinine ratio in a point of care setting. Clin. Nephrol. 51:1999;220-227.
14. Parsons M., Newman D.J., Newall R.G., Price C.P. Validation of a point-of-care assay for the urinary albumin:creatinine ratio. Clin. Chem. 45:1999;414-417.